BKH three-lens brief
Evidence-based stock research on BKH. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Analyst mean target $84.60 — 17% above current (5 analysts). · Negative free cash flow last quarterly (-$77.75M).
- Analyst mean target $84.60 — 17% above current (5 analysts).
- Negative free cash flow last quarterly (-$77.75M).
BKH closed at $72.28 (-0.74%) as of 2026-09-11. Market cap: $5.51B. P/E (trailing) 18.3. Price is below the 50-day MA and below the 200-day MA. Positives: analyst mean target $84.60 — 17% above current (5 analysts).. Concerns: negative free cash flow last quarterly (-$77.75M).. Last quarter: Revenue $452.80M, net income $38.20M, free cash flow -$77.75M.
Why three lenses on BKH, not one.
A single reasoning model has blind spots it doesn’t know about. We examine BKHacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/BKH" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath BKH brief"></iframe>